Ahmadian M, Roshan VD, Aslani E, Stannard SR. Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure. Ther Adv Cardiovasc Dis. 2017;11(7):185–94.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Aker S, Belosjorow S, Konietzka I, Duschin A, Martin C, Heusch G, Schulz R. Serum but not myocardial TNF-α concentration is increased in pacing-induced heart failure in rabbits. Am J Physiol Regul Integr Comp Physiol. 2003;285(2):R463–9.

Article  PubMed  CAS  Google Scholar 

Alhumaidha KA, Saleh DO, Abd El Fattah MA, El-Eraky WI, Moawad H. Cardiorenal protective effect of taurine against cyclophosphamide-induced toxicity in albino rats. Can J Physiol Pharmacol. 2016;94(2):131–9.

Article  PubMed  CAS  Google Scholar 

Azuma J, Sawamura A, Awata N, Ohta H, Hamaguchi T, Harada H, Takihara K, Hasegawa H, Yamagami T, Ishiyama T, et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol. 1985;8(5):276–82.

Article  PubMed  CAS  Google Scholar 

Azuma J, Sawamura A, Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J. 1992;56(1):95–9.

Article  PubMed  CAS  Google Scholar 

Bai H, Li T, Yu Y, Zhou N, Kou H, Guo Y, Yang L, Yan P. Cytoprotective effects of taurine on heat-induced bovine mammary epithelial cells in vitro. Cells. 2021;10(2):258.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Barbiera A, Sorrentino S, Fard D, Lepore E, Sica G, Dobrowolny G, Tamagnone L, Scicchitano BM. Taurine administration counteracts aging-associated impingement of skeletal muscle regeneration by reducing inflammation and oxidative stress. Antioxidants. 2022;11(5):1016.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Barış VÖ, Gedikli E, Yersal N, Müftüoğlu S, Erdem A. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings. Amino Acids. 2019;51:1649–55.

Article  PubMed  Google Scholar 

Bartlett JJ, Trivedi PC, Yeung P, Kienesberger PC, Pulinilkunnil T. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy. Biochem J. 2016;473(21):3769–89.

Article  PubMed  CAS  Google Scholar 

Belikova J, Lizogub V, Kuzminets A, Lavrenchuk I. Normalization of heart rate variability with taurine and meldonium complex in post-infarction patients with type 2 diabetes mellitus. J Med Life. 2019;12(3):290–5.

PubMed  PubMed Central  Google Scholar 

Besse HC, Chen Y, Scheeren HW, Metselaar JM, Lammers T, Moonen CT, Hennink WE, Deckers R. A doxorubicin-glucuronide prodrug released from nanogels activated by high-intensity focused ultrasound liberated β-glucuronidase. Pharmaceutics. 2020;12(6):536.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Beyranvand MR, Khalafi MK, Roshan VD, Choobineh S, Parsa SA, Piranfar MA. Effect of taurine supplementation on exercise capacity of patients with heart failure. J Cardiol. 2011;57(3):333–7.

Article  PubMed  Google Scholar 

Caine JJ, Geracioti TD. Taurine, energy drinks, and neuroendocrine effects. Cleve Clin J Med. 2016;83(12):895–904.

Article  PubMed  Google Scholar 

Chaix MA, Parmar N, Kinnear C, Lafreniere-Roula M, Akinrinade O, Yao R, Miron A, Lam E, Meng G, Christie A, Manickaraj AK. Machine learning identifies clinical and genetic factors associated with anthracycline cardiotoxicity in pediatric cancer survivors. Cardio Oncology. 2020;2(5):690–706.

Google Scholar 

Chen H, Zhu J, Le Y, Pan J, Liu Y, Liu Z, Wang C, Dou X, Lu D. Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway. Phytomedicine. 2022;99:153964.

Article  PubMed  CAS  Google Scholar 

Chesney RW. Taurine: its biological role and clinical implications. Adv Pediatr. 1985;32(1):1–42.

Article  PubMed  CAS  Google Scholar 

Chik MW, Hazalin NA, Singh GK. Regulation of phase I and phase II neurosteroid enzymes in the hippocampus of an Alzheimer’s disease rat model: a focus on sulphotransferases and UDP-glucuronosyltransferases. Steroids. 2022;184:109035.

Article  PubMed  CAS  Google Scholar 

Christidi E, Brunham LR. Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. 2021;12(4):339.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Das J, Ghosh J, Manna P, Sil PC. Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochem Pharmacol. 2011;81(7):891–909.

Article  PubMed  CAS  Google Scholar 

ErdogmusOzgen Z, Erdinc M, Kelle İ, Erdinc L, Nergiz Y. Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart. Hum Exp Toxicol. 2022;41:09603271211066066.

Article  CAS  Google Scholar 

Fu LX, Waagstein F, Hjalmarson Å. A new insight into adriamycin-induced cardiotoxicity. Int J Cardiol. 1990;29(1):15–20.

Article  PubMed  CAS  Google Scholar 

Gagliarducci U. Sul trattamento delle cardiopatie ischemichie acute con taurina. Osservazioni cliniche su trenta casi [Treatment of acute ischemic heart disease using taurine. Clinical study of 30 cases]. Clin Ter. 1974 Feb 15;68(3):261–70.

Ghanim AM, Farag MR, Anwar MA, Ali NA, Hawas MA, Elsallab HM, Elhendawy WA, Basyouni LA, Refaey OA, Zaki KE, Ali NA. Taurine alleviates kidney injury in a thioacetamide rat model by mediating Nrf2/HO-1, NQO-1, and MAPK/NF-κB signaling pathways. Can J Physiol Pharmacol. 2022;100(4):352–60.

Article  PubMed  CAS  Google Scholar 

Ghosh S, Chitgupi U, Sunar U, Lovell JF. Chemophototherapeutic ablation of doxorubicin-resistant human ovarian tumor cells. Photochem Photobiol. 2023;99(2):844–9.

Article  PubMed  CAS  Google Scholar 

Gutteridge JM. Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complex. Biochem Pharmacol. 1984;33(11):1725–8.

Article  PubMed  CAS  Google Scholar 

Hamaguchi T, Azuma J, Awata N, Ohta H, Takihara K, Harada H, Kishimoto S, Sperelakis N. Reduction of doxorubicin-induced cardiotoxicity in mice by taurine. Res Commun Chem Pathol Pharmacol. 1988;59(1):21–30.

PubMed  CAS  Google Scholar 

Hamaguchi T, Azuma J, Harada H, Takahashi K, Kishimoto S, Schaffer SW. Protective effect of taurine against doxorubicin-induced cardiotoxicity in perfused chick hearts. Pharmacol Res. 1989;21(6):729–34.

Article  PubMed  CAS  Google Scholar 

Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet. 1990;335(8684):294–5.

Article  PubMed  CAS  Google Scholar 

Husain N, Mahmood R. Taurine attenuates Cr (VI)-induced cellular and DNA damage: an in vitro study using human erythrocytes and lymphocytes. Amino Acids. 2020;52(1):35–53.

Article  PubMed  CAS  Google Scholar 

Ibrahim Fouad G, Ahmed KA. Curcumin ameliorates doxorubicin-induced cardiotoxicity and hepatotoxicity via suppressing oxidative stress and modulating iNOS, NF-κB, and TNF-α in rats. Cardiovasc Toxicol. 2022;22(2):152–66.

Article  PubMed  CAS  Google Scholar 

Ito H, Miller SC, Billingham ME, Akimoto H, Torti SV, Wade R, Gahlmann R, Lyons G, Kedes L, Torti FM. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci. 1990;87(11):4275–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ito T, Muraoka S, Takahashi K, Fujio Y, Schaffer SW, Azuma J. Beneficial effect of taurine treatment against doxorubicin-induced cardiotoxicity in mice. In: Azuma Junichi, Schaffer Stephen W, Ito Takashi,